Despite a fevered controversy over the reliability of the study that led to worldwide use of the AIDS drug nevirapine to protect newborns, doctors have begun testing a strategy for boosting the drug’s proven benefits.

Quoted: University of Wisconsin bioethicist Alta Charo.